%0 Journal Article
%A Shen, Jing
%A Najafi, Sara
%A Stäble, Sina
%A Fabian, Johannes
%A Koeneke, Emily
%A Kolbinger, Fiona
%A Wrobel, Jagoda
%A Meder, Benjamin
%A Distel, Martin
%A Heimburg, Tino
%A Sippl, Wolfgang
%A Jung, Manfred
%A Peterziel, Heike
%A Kranz, Dominique
%A Boutros, Michael
%A Westermann, Frank
%A Witt, Olaf
%A Oehme, Ina
%T A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatment.
%J Cell death and differentiation
%V 25
%N 12
%@ 1476-5403
%C London
%I Macmillan
%M DKFZ-2018-02364
%P 2053 - 2070
%D 2018
%X The prognosis of advanced stage neuroblastoma patients remains poor and, despite intensive therapy, the 5-year survival rate remains less than 50
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:29515255
%2 pmc:PMC6261943
%R 10.1038/s41418-018-0080-0
%U https://inrepo02.dkfz.de/record/142134